Pharmacy is where compliant OVHC runs out first

A policy can satisfy every requirement Home Affairs sets, cover your hospital admission in full, and still leave you unable to afford your medication. This is the most understated risk on any visitor policy, and the one the regulator warns about most directly.

The government’s own warning

There is no ambiguity in the official position. PrivateHealth.gov.au states that most overseas visitors’ health cover products have limited cover for pharmaceuticals, and that overseas visitors may face significant out-of-pocket costs if they need treatment with pharmaceuticals, particularly cancer treatment.

Home Affairs says the same thing about the minimum level of cover: products like this are only required to provide limited cover of pharmaceuticals, and if you are likely to require pharmaceuticals you may wish to explore increasing the cover above that provided under an OSHC, or similar, product.

The consumer guidance goes further and is specific about why: check how much your policy will cover for pharmaceuticals as most policies only have limited cover and will not adequately cover high-cost drugs such as those used as chemotherapy drugs in cancer treatment, which can cost tens of thousands of dollars.

When the regulator singles out one category this way, it is telling you where the money goes.

What the minimum actually covers

Home Affairs’ minimum requirement is narrower than most people assume. For all PBS-listed drugs, prescribed according to PBS-approved indications, that are administered during and form part of an admitted episode of care, the benefit is equal to the PBS-listed price above your patient contribution.

Three conditions, all of which must hold:

1. The drug is on the PBS list.
2. It is prescribed for a PBS-approved indication.
3. It is administered during and as part of an admitted episode of care.

Post-discharge drugs count only if they remain part of that admitted episode. This is where the practical gap opens: a drug you take at home after leaving hospital is no longer part of the admitted episode, and the minimum cover no longer reaches it.

The four gaps that follow from that definition

Gap one: the outpatient script. A prescription written by a GP for a condition you are managing as an outpatient is not administered during an admitted episode. The minimum cover does not reach it.

Gap two: ongoing medication for a chronic condition. If you arrived with a condition you already manage with daily medication, you are taking that medication for the entire policy term and none of it is part of an admitted episode.

Gap three: high-cost drugs. Chemotherapy and other high-cost treatments are precisely where “limited cover” becomes “significant out-of-pocket cost”. The regulator names this case explicitly.

Gap four: non-PBS medicines. Many newer, specialist and some common medicines are not PBS-listed at all. A drug outside the PBS is outside the minimum entirely, however necessary it is.

What you can do about it

There is no OVHC product that makes this disappear. The available levers are:

1. Buy above the minimum. Home Affairs explicitly invites this where you are likely to require pharmaceuticals. Higher-level products may carry broader pharmaceutical benefits — check the PDS for the pharmacy schedule, not the headline benefit summary.
2. Check the waiting period for your specific condition and medication. The general 2-month cap applies to all other treatments, and 12 months to pre-existing conditions. Our waiting periods guide sets out the caps.
3. Ask what the pharmacy benefit actually is before you buy: which drugs, what percentage, what annual limit, and whether outpatient prescriptions are included at all.
4. Ask the treating provider for the cost in advance. The consumer guidance recommends that if you need treatment which is not covered by your insurer, you ask the service provider how much you will need to pay out of your own pocket, and if possible to ask for a written quote.
5. Contact your insurer before treatment if you anticipate it. The guidance says if you are anticipating treatment, contact your insurer and find out whether you will be covered and how much you will need to pay yourself.

Bringing medication with you

There is a separate route that is genuinely useful for stable medication you already take.

The Therapeutic Goods Administration explains that travellers entering Australia may bring in medicines and medical devices for immediate use, and to import small quantities for personal use under the Personal Importation Scheme.

Two boundaries worth respecting: it is for personal use in small quantities, not supply; and the medicine must be one you are legally entitled to possess and use in Australia. The TGA pages on entering Australia and the Personal Importation Scheme cover the detail.

This helps if you are stable on a long-term medication. It does nothing for a treatment that begins in Australia.

How to compare on pharmacy cover

Pharmacy is where products that look identical on premium diverge. When you compare, look for these lines specifically:

• Is outpatient prescription cover included, or only drugs administered as part of an admission?
• What percentage of the cost is payable, and against the PBS price or the retail price?
• Is there an annual pharmacy limit, and how high?
• Are high-cost drugs excluded or capped?
• What is the pharmacy waiting period — the general 2-month cap, or longer for a pre-existing condition?

If you or a family member has an ongoing prescription or is planning treatment that involves medication, this is the axis on which to compare, ahead of price. Compare current OVHC quotes in one view, then check the pharmacy schedule in each PDS before you commit. Pharmaceutical benefits vary between products; check the current Product Disclosure Statement. General information only; not financial, medical or migration advice.